EMFAT
PVLA

Emerald Mutual Fund Advisers Trust’s Palvella Therapeutics PVLA Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Buy
+105,820
New +$11M 0.64% 69
2015
Q4 		– Sell
-11,858
Closed -$1.74M – 297
2015
Q3 		$1.74M Buy
11,858
+538
+5% +$120K 0.11% 157
2015
Q2 		$2.49M Buy
+11,320
New +$2.49M 0.19% 120

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PVLA Position: Q1 2026 in Review

Emerald Mutual Fund Advisers Trust opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 105,820 shares worth $13.2M. The stake represents 0.64% of the portfolio and ranks #69 among its holdings. This is a return to the name: Emerald Mutual Fund Advisers Trust previously reported a position in PVLA as recently as Q3 2015.

Emerald Mutual Fund Advisers Trust first reported a position in PVLA in Q2 2015 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Emerald Mutual Fund Advisers Trust held 105,820 shares of Palvella Therapeutics worth $13.2M as of Q1 2026.
  • Palvella Therapeutics was a new Emerald Mutual Fund Advisers Trust position in Q1 2026.
  • Palvella Therapeutics made up 0.64% of Emerald Mutual Fund Advisers Trust's portfolio in Q1 2026, its #69 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Palvella Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2026, filed 4 May 2026.